Skip to main content

Advertisement

Table 1 Comparison of G2/M phase induction by α-santalol in A431 cells and UACC-62 cells

From: Alpha-santalol, a chemopreventive agent against skin cancer, causes G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells

Time of treatment Conc. of α-santalol (μM) Percentage of G2/M phase induction by α-santalol as compared to control *
   p53 mutated human epidermoid carcinoma A431 cells p53 wild-type human melanoma UACC-62 cells
6 h 50 49.1 70.9
  75 48.8 65.2
12 h 50 171.1 148.7
  75 235.5 149
24 h 50 27.2 226
  75 285 305.5
  1. *: Data were expressed as the percentage of the induction of α-santalol treated groups in G2/M phase to untreated controls.